James Robl, Ph.D., received his
Ph.D. from the University of Illinois in 1983 and conducted post-doctoral
research at the University of Wisconsin from 1983 to 1985. He then was a
professor at the University of Massachusetts for 15 years. Dr. Robl is
now the president and chief scientific officer for Hematech, one of several
biotechnology companies he co-founded. Dr. Robls research has focused on
mammalian cloning and genetic modification. He developed the procedure
that is used today for cloning in cattle, and other species, and his laboratory
was the first to produce calves from genetically modified somatic cells.
To return to previous topic, click on your browser's 'Back' button.